Chargement en cours...
PRAS40 Is an Integral Regulatory Component of Erythropoietin mTOR Signaling and Cytoprotection
Emerging strategies that center upon the mammalian target of rapamycin (mTOR) signaling for neurodegenerative disorders may bring effective treatment for a number of difficult disease entities. Here we show that erythropoietin (EPO), a novel agent for nervous system disorders, prevents apoptotic SH-...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Public Library of Science
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3445503/ https://ncbi.nlm.nih.gov/pubmed/23029019 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0045456 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|